Hostname: page-component-77f85d65b8-hzqq2 Total loading time: 0 Render date: 2026-04-19T18:33:09.119Z Has data issue: false hasContentIssue false

Authority and ownership: the growth and wilting of medicine patenting in Georgian England

Published online by Cambridge University Press:  24 November 2016

ALAN MACKINTOSH*
Affiliation:
School of Philosophy, Religion and History of Science, University of Leeds, Leeds, LS2 9JT, UK. Email: alanmackintosh@btinternet.com.

Abstract

Secret, owned, Georgian medicines were normally known as patent medicines, though few had a current patent. Up to 1830, just 117 medicines had been patented, whilst over 1,300 were listed for taxation as ‘patent medicines’. What were the benefits of patenting? Did medicine patenting affect consumer perception, and how was this used as a marketing tool? What were the boundaries of medical patenting? Patents for therapeutic preparations provided an apparent government guarantee on the source and composition of widely available products, while the patenting of medical devices seems to have been used to grant a temporary monopoly for the inventor's benefit.

Information

Type
Research Article
Copyright
Copyright © British Society for the History of Science 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable